Minimally-Invasive Implantation of Living Tissue Engineered Heart Valves
Abstract
No abstract availableKeywords
Funding Information
- Center for Integrative Human Physiology, University Zurich
- Dutch Program for Tissue Engineering
- Xeltis Inc.
- European Union–funded project “Intelligent Biomaterial Systems for Cardiovascular Tissue Repair
- BIOSYS (STRP 013633)
This publication has 24 references indexed in Scilit:
- Hypoxia Induces Near-Native Mechanical Properties in Engineered Heart Valve TissueCirculation, 2009
- NEW PERCUTANEOUS TREATMENTS FOR VALVE DISEASEHeart, 2007
- Endothelial Progenitor and Mesenchymal Stem Cell–Derived Cells Persist in Tissue-Engineered Patch In Vivo : Application of Green and Red Fluorescent Protein–Expressing Retroviral VectorTissue Engineering, 2007
- Human Pulmonary Valve Progenitor Cells Exhibit Endothelial/Mesenchymal Plasticity in Response to Vascular Endothelial Growth Factor-A and Transforming Growth Factor-β 2Circulation Research, 2006
- Prevention of device-related tissue damage during percutaneous deployment of tissue-engineered heart valvesThe Journal of Thoracic and Cardiovascular Surgery, 2006
- Tissue Engineering of Human Heart Valve Leaflets: A Novel Bioreactor for a Strain-Based Conditioning ApproachAnnals of Biomedical Engineering, 2005
- Fibrin as a cell carrier in cardiovascular tissue engineering applicationsBiomaterials, 2005
- Percutaneous Valve Replacement: Current State and Future ProspectsThe Annals of Thoracic Surgery, 2004
- New Pulsatile Bioreactor for In Vitro Formation of Tissue Engineered Heart ValvesTissue Engineering, 2000
- Multilineage Potential of Adult Human Mesenchymal Stem CellsScience, 1999